“Exciting” Cancer Drug Combination Shrinks Tumors and Stops Growth Where Other Treatments Failed, Early Trial Suggests
An ”exciting” new cancer drug combination appears to shrink tumors and halt their growth for months, according to an early-stage clinical trial which could mean months of extra life for patients.